Charles River Laboratories (CRL) Tops Q3 EPS by 9c ; Offers Guidance
Tweet
Share
E-mail
Get Alerts CRL Hot Sheet
Price: $286.75 +2.39%
Financial Fact:
Amortization of intangibles: 11.83M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Amortization of intangibles: 11.83M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Charles River Laboratories (NYSE: CRL) reported Q3 EPS of $2.43, $0.09 better than the analyst estimate of $2.34. Revenue for the quarter came in at $1 billion versus the consensus estimate of $987.43 million.
GUIDANCE:
Charles River Laboratories sees FY2025 EPS of $10.10-$10.30, versus the consensus of $10.19.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Is Treasury selloff a major issue for stock market bulls?
- Brean Capital Upgrades Columbia Financial Inc (CLBK) to Buy
- OLB Group narrows net loss 50% as revenue falls in Q2 2026
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
